The frequency of intrathecal antibody production to Epstein-Barr virus (EBV) in multiple sclerosis (MS) patients is surprisingly low compared to that of other microbial agents. This was shown in a collaborative study between EUROIMMUN and scientists at Charité Universitätsmedizin Berlin. The finding is intriguing given the strong link between EBV and MS. EBV is presumed […]
Press release, March 3rd 2025 Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus. EUROIMMUN’s Anti-Measles Virus ELISA 2.0 (IgG) is the first of several assays in development expanding EUROIMMUN’s
A new study has shown that mRNA vaccines against SARS-CoV-2 do not induce short-term worsening of autoimmunity in patients with autoimmune liver diseases (AILD). The collaborative study between EUROIMMUN and researchers at the Epatocentro Ticino, Lugano and other institutes and clinics in Switzerland was published recently in the Journal of Autoimmunity. The mRNA vaccines against
Serum uromodulin (sUmod) represents a promising biomarker for acute kidney injury (AKI) in COVID-19 patients, as reported in a published collaborative study between EUROIMMUN, St Georg Hospital (Leipzig, Germany) and further institutes and clinics. AKI is a frequent complication in patients hospitalized with COVID-19 and is associated with an increased risk of fatal outcomes. Early
With passion for rheumatology! Systemic autoimmune rheumatic diseases encompass a wide range of different inflammatory joint, tissue and vascular diseases, such as rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. They are diagnosed on the clinical history, imaging techniques, and serological tests. Antibody detection is a useful diagnostic tool and can provide essential information for
